VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $364,000 | -2.9% | 22,838 | +5.5% | 0.02% | -20.8% |
| Q2 2017 | $375,000 | +73.6% | 21,651 | +10.5% | 0.02% | +100.0% |
| Q1 2017 | $216,000 | -58.0% | 19,600 | -44.7% | 0.01% | -61.3% |
| Q4 2016 | $514,000 | -21.5% | 35,415 | +32.7% | 0.03% | -11.4% |
| Q3 2016 | $655,000 | +26.2% | 26,697 | +3.6% | 0.04% | +20.7% |
| Q2 2016 | $519,000 | -91.6% | 25,767 | -89.1% | 0.03% | -92.7% |
| Q1 2016 | $6,197,000 | +259.0% | 235,623 | +1287.4% | 0.40% | +370.2% |
| Q4 2015 | $1,726,000 | -85.6% | 16,983 | -74.7% | 0.08% | -85.7% |
| Q3 2015 | $11,967,000 | +38.5% | 67,085 | +72.5% | 0.59% | +77.1% |
| Q2 2015 | $8,641,000 | +12.6% | 38,899 | +0.7% | 0.33% | +8.9% |
| Q1 2015 | $7,671,000 | +313.8% | 38,623 | +162.7% | 0.30% | +267.5% |
| Q2 2014 | $1,854,000 | -73.5% | 14,701 | -72.3% | 0.08% | -83.3% |
| Q1 2014 | $6,999,000 | – | 53,092 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |